ABC240621P180000
- 10.70
- 0.000.00%
AmerisourceBergen Newsroom
Form 144 | Cencora(COR.US) Insider Proposes to Sell 447.9K in Common Stocks
SEC FILLINGS DISCLOSED/ May 7, $AmerisourceBergen(ABC.US)$、$Cencora(COR.US)$ Insider Lon Greenberg intends to sell 2,000 shares of its common stock on May 7, with a total market value of approximately
Form 144 | Cencora(COR.US) Officer Proposes to Sell 2.55 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 16, $AmerisourceBergen(ABC.US)$、$Cencora(COR.US)$ Officer COLLIS STEVEN H intends to sell 10,754 shares of its common stock on Apr 16, with a total market value of approxim
Form 144 | Cencora(COR.US) Officer Proposes to Sell 13.53 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 15, $Cencora(COR.US)$、$AmerisourceBergen(ABC.US)$ Officer Mauch Robert P. intends to sell 57,564 shares of its common stock on Apr 15, with a total market value of approxim
News On AmerisourceBergen Corp. (ABC) Now Under COR
News On AmerisourceBergen Corp. (ABC) Now Under COR
AmerisourceBergen Becomes Cencora, in Alignment With the Company's Growing Global Footprint and Central Role in Pharmaceutical Access and Care
New name of company reflects unified global presence and collective goal of creating healthier futures by accelerating positive outcomes for customers and their patients Company announces more than $5 million
Outlook Therapeutics Plunges as FDA Rejects Wet AMD Therapy
Tivic Health System Spike On Agreement With AmerisourceBergen
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
Tivic To Offer Sinus Pain Relief Device In Retail Pharmacy Marketplace Via AmerisourceBergen's Platform
Tivic Health Systems, Inc. (NASDAQ:TIVC) inked a pact to make its products available on AmerisourceBergen Corporation's (NYSE:ABC) third-party marketplace. Tivic's patented ClearUP bioelectronic sinus
Tivic Health Signs Agreement With AmerisourceBergen for Retail Pharmacy Customers
Tivic Health Systems, Inc. (("Tivic", "Company", NASDAQ:TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that the Company has entered into a non-exclusive
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today
AmerisourceBergen (NYSE:ABC) has outperformed the market over the past 10 years by 1.81% on an annualized basis producing an average annual return of 12.13%. Currently, AmerisourceBergen has a market
Looking Into AmerisourceBergen's Recent Short Interest
AmerisourceBergen's (NYSE:ABC) short percent of float has risen 3.83% since its last report. The company recently reported that it has 3.92 million shares sold short, which is 2.44% of all regular sha
Ozempic, Weight-Loss Drugs Carry Costly, Complicated Logistics -- WSJ
By Liz Young The soaring popularity of Ozempic and similar weight-loss drugs is driving big business for some of the largest pharmaceutical distributors in the U.S. But the benefits aren't necessaril
Blue Shield of California New Pharmacy Care Model Could Face Execution Risks, Analysts Say
Blue Shield of California's new pharmacy care model that seeks to lower reliance on CVS Health's (CVS) pharmacy benefit management services could face executions risks, while the negative market react
AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors has elected Werner Baumann and Lauren M. Tyler as new independent directors, e
Why Better-Than-Expected Earnings Results Are Hard for Investors to Buy into Anymore
Despite beating earnings estimates, companies received little reward from investors.
J.P. Morgan Reaffirms Their Buy Rating on AmerisourceBergen (ABC)
Supreme Court Blocks Purdue Pharma's $6B Sackler Opioid Settlement
Supreme Court Blocks Purdue Pharma's $6B Sackler Opioid Settlement
Express News | Insider Sell: Amerisourcebergen
If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,200 Today
AmerisourceBergen (NYSE:ABC) has outperformed the market over the past 20 years by 5.53% on an annualized basis producing an average annual return of 13.27%. Currently, AmerisourceBergen has a market